Plant‐produced SARS‐CoV‐2 antibody engineered towards enhanced potency and in vivo efficacy
Prevention of severe COVID-19 disease by SARS-CoV-2 in high-risk patients, such as immuno-compromised individuals, can be achieved by administration of antibody prophylaxis, but producing antibodies …